Tocris Bioscience Announces The Opening Of New UK Laboratory Facilities
Published: Oct 31, 2005
BRISTOL, England--(BUSINESS WIRE)--Oct. 31, 2005--Tocris Bioscience (Bristol, UK) announced the opening of new laboratories at the IO Centre, Bristol. Developed to meet the needs of Tocris' Production, R&D and Quality Control operations the new labs have a flexible open-plan layout based around a well-equipped central analytical laboratory. Currently 700 sq m (7,000 sq ft) in size, the labs have been designed with future growth in mind and feature advanced environmental controls and fully integrated IT systems. "These new labs are a tremendous boost to Tocris' production capabilities and exactly what we need to keep us at the cutting edge of scientific research," said Dr. David Peters, Tocris' Head of Supply Chain. Managing Director, Laurence Ede added, "Our GBP 700,000 ($1.2 million) investment in these laboratories underlines Tocris' absolute commitment to being the undisputed supplier of choice in the life science sector." Tocris is currently in the process of expanding its laboratory team, with plans to double the number of lab staff by 2008. The new facility was built to accommodate this growth and is in addition to Tocris' other laboratory facilities located in Sussex, UK. About Tocris Bioscience Tocris Bioscience (www.tocris.com) is a leading supplier of chemicals, peptides and antibodies for Life Science research, with customers in virtually all of the world's major pharmaceutical companies, universities and research institutes. The Company's catalogue of over 1,500 products is sent to more than 50,000 researchers worldwide annually.